{
    "Trade/Device Name(s)": [
        "CDC Human Influenza Virus Real-time RT-PCR Diagnostic Panel: Influenza A/B Typing Kit (VER 2)",
        "Influenza A Subtyping Kit (VER 4)",
        "Influenza B Lineage Genotyping Kit (VER 1.1 and 2)",
        "Influenza A/H5 Subtyping Kit (VER 4)"
    ],
    "Submitter Information": "Centers for Disease Control and Prevention",
    "510(k) Number": "K243931",
    "Predicate Device Reference 510(k) Number(s)": [
        "K190302"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OZE"
    ],
    "Summary Letter Date": "December 16, 2024",
    "Summary Letter Received Date": "December 20, 2024",
    "Submission Date": "December 16, 2024",
    "Regulation Number(s)": [
        "21 CFR 866.3980"
    ],
    "Regulation Name(s)": [
        "Respiratory Viral Panel Multiplex Nucleic Acid Assay"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Influenza A virus RNA",
        "Influenza B virus RNA",
        "A(H1N1)pdm09",
        "A(H3N2)",
        "B/Victoria lineage",
        "B/Yamagata lineage",
        "Influenza A(H5) (Asian lineage)",
        "Human RNase P gene (RP)"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swab",
        "Nasal swab",
        "Throat swab",
        "Nasal aspirate",
        "Nasal wash",
        "Dual nasopharyngeal/throat swab",
        "Bronchoalveolar lavage",
        "Bronchial wash",
        "Tracheal aspirate",
        "Sputum",
        "Lung tissue",
        "Viral culture",
        "Conjunctival swab"
    ],
    "Specimen Container(s)": [
        "Viral transport medium (VTM)",
        "Universal transport medium (UTM)"
    ],
    "Instrument(s)/Platform(s)": [
        "Applied Biosystems 7500 Fast Dx Real-time PCR system",
        "Applied Biosystems QuantStudio Dx",
        "QIAGEN Rotor-Gene Q MDx"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time RT-PCR"
    ],
    "Methodologies": [
        "RT-PCR",
        "Multiplex nucleic acid amplification",
        "Viral RNA detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Reagent",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for CDC Human Influenza Virus Real-time RT-PCR Diagnostic Panel (A/B Typing, A Subtyping, B Lineage Genotyping, and A/H5 Subtyping Kits) for qualitative detection, characterization, and surveillance of influenza viruses using real-time RT-PCR.",
    "Indications for Use Summary": "For qualitative detection and characterization of influenza virus (type A/B, subtypes H3 and H1pdm09, B lineages, and presumptive A/H5) RNA in respiratory and conjunctival specimens and/or viral culture to aid in patient diagnosis and influenza surveillance.",
    "fda_folder": "Microbiology"
}